Norway-based Nordic Nanovector ASA (OSE: NANO) has named Dr Christine Wilkinson Blanc as its new Chief Medical Officer effective immediately, it was reported on Monday.

Dr Blanc has more than 25 years of experience in the pharmaceutical industry. She was the medical director of Phi-Medics for 10 years. She was also the medical director in Oncology for various companies including Ariad Pharma, Roche, GE Healthcare and Aventis.

Lars Nieba, Nano's interim chief executive officer, said, 'I am very pleased that Christine has joined Nordic Nanovector as CMO. Her vast experience in clinical development, particularly in oncology and haematology, will be invaluable as we focus our resources and energy on completing the PARADIGME study.'